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Abstract
 
We observed here that the expression of B lymphocyte chemokine (BLC/CXCL13) was
markedly enhanced in the thymus and kidney in aged (NZB 
 

 
 NZW)F1 (BWF1) mice devel-
oping lupus nephritis, but not in similarly aged NZB and NZW mice. BLC-positive cells were
present in the cellular infiltrates in the target organs with a reticular pattern of staining.
CD11b
 

 
CD11c
 

 
 dendritic cells were increased in the thymus and spleen in aged BWF1 mice
and identified as the major cell source for BLC. CD4
 

 
 T cells as well as B cells were dramati-
cally increased in the thymus in aged BWF1 mice, whereas no increase was observed in aged
NZB and NZW mice. B1/B2 ratio in the thymus was significantly higher than those in the
spleen and peripheral blood in aged BWF1 mice. Interestingly, BLC showed preferential
chemotactic activity for B1 cells derived from several mouse strains, including nonautoimmune
mice. Cell surface CXCR5 expression on B1 cells was significantly higher than that on B2
cells. Thus, aberrant high expression of BLC by myeloid dendritic cells in the target organs in
aged BWF1 mice may play a pivotal role in breaking immune tolerance in the thymus and in
recruiting autoantibody-producing B cells in the development of murine lupus.
Key words: chemokine • lupus • dendritic cells • B1 cells • T cells
 
Introduction
 
It is generally believed that autoimmune diseases result
from breakdown in immunological tolerance (1). (NZB 
 

 
NZW)F1 (BWF1) mice spontaneously develop systemic
autoimmune disorders resembling SLE in humans (2, 3). It
is characterized by production of a variety of IgG autoanti-
bodies and massive deposition of immune complexes in
glomeruli in the kidney. More than 95% of these mice die
from renal failure before 12 mo of age. A marked mononu-
clear cell infiltration in the target organs including the kid-
ney and lung is another characteristic in aged BWF1 mice.
The mechanism and pathophysiological significance for
mononuclear cell infiltration in the target organs in the de-
velopment of SLE, however, remain largely unknown.
Recent advances in molecular and biological analysis on
chemokine/chemokine receptors have revealed pivotal
roles of these proteins in inflammatory cellular infiltration
(4). Chemokines and their receptors also play a pivotal role
in linking innate immunity with acquired immunity
through regulating dendritic cell (DC)
 
1
 
 trafficking (5–8). It
is now widely accepted that dysregulation of Th1/Th2 bal-
ance is a general feature of autoimmune diseases in the on-
set, progression, and prognosis (9, 10).
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On the other hand, B1 cells which have different origin
and function from conventional B cells (B2 cells) have long
been considered to be involved in autoantibody production
in autoimmune diseases (11–13). They produce IgM natu-
ral Abs in serum and contribute to IgA-producing plasma
cells in the lamina propria in the gut (14). Involvement of
B1 cells in IgM-mediated autoimmune diseases such as au-
toimmune hemolytic anemia was also demonstrated (15,
16). However, it remains to be elucidated whether Ig class
switching from IgM to IgG occurs in B1 cells in the devel-
opment of autoimmune diseases. There is accumulating ev-
idence suggesting that B cell receptor (BCR)-mediated sig-
naling by autoantigens is essential for induction of B1 cell
phenotype and that B1 cells can be induced from adult pre-
cursors by appropriate Ag (17).
We hypothesized that aberrant chemokine expression
could be a cause for activation of autoreactive T and B cells
through abnormal cell trafficking and localization in the ab-
sence of any defect in the machinery for immunological
tolerance. We examined the chemokine expression in the
lesions of lupus mice and found that the expression of B
lymphocyte chemokine (BLC) was markedly enhanced in
aged BWF1 mice. Our findings would provide a novel un-
derstanding of SLE as a chemokine disorder where aberrant
high expression of BLC by DCs and preferential chemo-
taxis of B1 cells towards BLC may play a pivotal role in the
development of murine lupus.
 
Materials and Methods
 
Mice.
 
BWF1 mice, originally obtained from the Shizuoka
Laboratory Animal Center (Shizuoka, Japan), were maintained in
our animal facility at The University of Tokyo. Female mice aged
2 mo were used as young mice, while 8–12-mo-old mice with
moderate to severe proteinuria were used as aged mice.
 
Abs.
 
Rat mAbs specific for mouse CD4 (GK1.5), CD8 (53-
7.6), CD35 (8C12), CD11b (M1/70), CD11c (HL-3), B220/
CD45R (RA3-6B2), CD5 (53-7.3RRH), F4/80 (CI:A3-1), and
MHC class II (ER-TR3) were purchased from BD PharMingen.
Goat anti-BLC pAb was purchased from Genzyme. Follicular
DC (FDC)-M1, FDC-specific mAb, was a gift from Dr. K.
Maeda (Yamagata University School of Medicine, Yamagata, Ja-
pan). mAb for anti-CXCR5 mAb (2G8) was produced as de-
scribed previously (18).
 
Reverse Transcription PCR Analysis on Chemokine Expression.
 
Total cellular RNA was isolated from lymphoid cells or various
organs using RNeasy (QIAGEN) according to the manufacturer’s
instructions. In some experiments, cells purified by flow cytome-
ter (FCM) sorting or MACS
 
®
 
 magnetic beads (Miltenyi Biotec)
were used for RNA preparation. It was then reverse transcribed
into cDNA using Superscript II preamplification kit (Life Tech-
nologies) and amplified with specific oligonucleotide primers
(BLC, sense 5
 

 
-TCTCTCCAGGCCACGGTATTCT-3
 

 
, anti-
sense, 5
 

 
-ACCATTTGGCACGAGGATTCAC-3
 

 
; glyceralde-
hyde-3-phosphate dehydrogenase [G3PDH], sense 5
 

 
-AGTAT-
GACTCCACTAACGGCAA-3
 

 
, antisense, 5
 

 
-TCTCGCTC-
CTGGAAGATGGT-3
 

 
). PCR was performed by a thermal cy-
cler for 35 cycles of 94
 

 
C for 45 s, 55
 

 
C for 60 s, and 72
 

 
C for 90 s,
and final extension was done at 72
 

 
C for 10 min. BLC amplicon
was detected as a 300-bp product on 2.5% agarose gels. Real-
time quantitative PCR analysis was performed by using ABI 7700
sequence detector system (PE Biosystems). FAM (6-carboxyfluo-
rescein)-labeled primers were used as target hybridization probes
for BLC and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (BLC, 5
 

 
-CATCATAGTTCGGATTCAAGTTAC-
GCCCCC-3
 

 
; GAPDH, 5
 

 
-AAGGGACACAGTCAAGGC-
CGAGAAT-3
 

 
). The thermal cycling conditions included 50
 

 
C
for 2 min and 95
 

 
C for 10 min, followed by 50 cycles of amplifi-
cation at 95
 

 
C for 15 s and 55
 

 
C for 1.5 min for denaturing and
annealing, respectively. PCR reactions were run in triplicate.
BLC quantity in aged mice was normalized by the level of
GAPDH and compared with that in young mice. BLC quantity
in purified cell population obtained from the same lymphoid or-
gans was expressed relative to normalized BLC quantity in whole
splenic or thymic cells.
 
Histological and Immunohistochemical Examination.
 
Cryostat sec-
tions (3-
 

 
m thick) of kidney and the thymus were stained
with goat anti-BLC pAb, followed by biotinylated rabbit anti–
goat IgG (Dako) and horseradish peroxidase (HRP)-labeled
streptavidin (Dako). To decrease nonspecific staining, avidin/bi-
otin blocking solution (Vector Laboratories) and normal rabbit
IgG was used between each step. HRP-labeled goat anti–rat Ab
(Biosource International) was used for staining of CD4, CD8,
CD11b, CD35, B220, F4/80, MHC class II, and FDC-M1.
HRP-labeled streptavidin (Dako) was used as a second reagent
for staining with biotin-labeled anti-CD11c mAb.
 
Flow Cytometric Analysis.
 
Aliquots of 10
 
6
 
 spleen cells were in-
cubated with PE-labeled anti-B220 and FITC-conjugated anti-
CD5 mAbs. For four color staining, thymocytes were stained
with FITC-conjugated mAb, PE-conjugated mAb, and biotiny-
lated mAb, followed by Alexa-594–labeled mAb and allophyco-
cyanin (APC)-conjugated streptavidin. For staining for CXCR5
molecules on B1 or B2 cells, a mixture of spleen and peritoneal
cells was stained with 2G8 culture supernatants (1:4) followed by
PE-labeled F(ab
 

 
)
 
2 
 
goat anti–rat IgG pAb (Southern Biotechnol-
ogy Associates, Inc.). Cells were then blocked by normal rat IgG
and stained with FITC-labeled anti-B220 and biotin-labeled anti-
CD5 mAbs followed by APC-streptavidin. Flow cytometric
analysis and cell sorting was carried out using FACStar
 
PLUS™
 
(Becton Dickinson) with CELLQuest™ software (Becton Dick-
inson) or using EPICS ELITE
 
®
 
 (Beckman Coulter). The purity
of sorted cells exceeded 95%.
 
Chemotaxis Assay.
 
Chemotaxis assay using ChemoTx plate
(Neuro Probe) was performed according to the manufacturer’s
instructions. In brief, spleen cells were suspended at 10
 
6
 
 cells/ml
in RPMI 1640 containing 0.5% BSA and 20 mM HEPES. 60 
 

 
l
of cell suspension was loaded on the membrane plate and placed
onto a flat-bottomed microtiter plate with 96 wells containing 30
 

 
l of serially diluted BLC solution in each well. The plate was
then incubated at 37
 

 
C for 90 min and migrated cells were col-
lected. Cells were then stained with FITC-labeled anti-CD5 and
PE-labeled anti-B220 mAbs and counted on an EPICS ELITE
cell sorter. Chemotaxis assays for B1 and B2 cells were per-
formed on the same plate and on the same day in each experi-
ment because the absolute migrated cells varies in each chemo-
taxis assay. For chemotaxis assay for purified B1 and B2 cells, the
mixture of 5 
 

 
 10
 
6
 
 spleen and the peritoneal cells from young
BWF1 mice was stained with FITC-labeled anti-CD5 and PE-
labeled anti-B220 mAbs and subjected to cell sorting using an
EPICS ELITE cell sorter. The purity of B1 and B2 cells was
 

 
95% in all experiments.
 
Statistical Analysis.
 
Statistical analysis was performed using
Student’s 
 
t
 
 test. The 95% confidence limit was taken as significant.
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Results
 
Marked Increase in BLC Expression in the Target Organs of
Aged BWF1 Mice Developing Lupus Nephritis.
 
Histological
examination showed that a massive mononuclear cell infil-
tration in the kidney and the lung, but not in the liver in
aged BWF1 mice developing lupus nephritis (Fig. 1 A).
Cellular infiltrates are usually observed around the renal ar-
tery and arcuate arteries in the kidney and around pulmo-
nary arteries in the lung.
 
 
 
Reverse transcription (RT)-PCR
analysis revealed that BLC gene expression was markedly
increased in the kidney and the thymus in aged BWF1
mice compared with that in young mice (Fig. 1 B).
Quantitative difference in BLC expression in the thymus
and the kidney between young and aged BWF1 mice was
confirmed by real-time PCR analysis (Fig. 1 B, b). Ex-
tremely high magnification of BLC expression was observed
in the thymus and the kidney of aged BWF1 mice com-
pared with normalized BLC quantity in young BWF1 mice
(2,004 
 

 
 296 and 483 
 

 
 50-fold, respectively). Expression
of several other chemokines such as monokine induced by
IFN-
 
	 
 
(Mig) and regulated upon activation, normal T cell
expressed and secreted (RANTES) were also increased in
the thymus and the kidney in aged BWF1 mice compared
with young mice, whereas thymus and activation-regulated
chemokine (TARC), monocyte chemoattractant protein 1
(MCP-1), and macrophage inflammatory protein (MIP)-1a
were not detected in RT-PCR analysis (data not shown).
BLC expression was also increased in enlarged draining LNs
for the lung and the kidney (data not shown). Immunohis-
tochemical staining for BLC with anti-BLC pAbs demon-
strated the presence of BLC-positive cells in the cellular
Figure 1. Marked increase in BLC expression in the kidney and the thymus in aged BWF1 mice. (A) Hematoxylin and eosin staining of paraffin-embed-
ded sections from the kidney, lung, and liver in aged BWF1 mice developing lupus nephritis. A representative histology from 10 examinations of aged
BWF1 mice is presented. Similar histological findings were obtained in other examinations. (B, a) RT-PCR analysis was performed on total cellular RNAs
obtained from the spleen (Spl), thymus (Thy), lung, kidney (Kid), and liver of young and aged BWF1 mice. A representative result from four independent
experiments is presented. Similar results were obtained in other experiments. (b) Real-time quantitative PCR was performed as described in Materials and
Methods. BLC quantity in aged mice was normalized by the level of GAPDH and compared with that in young mice. The results were expressed as mean
magnification (fold)  SD for triplicate samples. A representative result from three independent experiments is presented. Similar results were obtained in
other experiments. *P 
 0.01, **P 
 0.001. (C) Kidney cryosections from aged BWF1 mice were stained with goat anti-BLC pAbs followed by biotiny-
lated rabbit anti–goat pAb and HRP-labeled streptavidin. Representative pictures from one of three aged BWF1 mice are presented. (D, a) RNAs obtained
from spleen cells, LN cells, and thymic cells of similarly aged NZB, NZW, and BWF1 mice were used for RT-PCR. Similar level of PCR products for
GAPDH were obtained (not shown). Three mice for each strain were examined and similar results were obtained. (b) Real-time quantitative PCR analysis
on thymic cells obtained from similarly aged NZB, NZW, and BWF1 mice. BLC quantity in aged mice was normalized by the level of GAPDH and com-
pared with that in young mice. The results were expressed as mean magnification (fold)  SD for triplicate samples. A representative result from three inde-
pendent experiments is presented. Similar results were obtained in other experiments. *P 
 0.01, **P 
 0.001.
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infiltrates in the kidney and the thymus with a reticular
pattern of staining (Fig. 1 C). Many B cells, CD4
 

 
 T cells,
F4/80
 

 
 macrophages, but a few CD8 T cells were present
in the cellular infiltrates, and MHC class II molecules were
strongly expressed in the entire region of the infiltrates (data
not shown). Similar results were obtained with the infil-
trated lung (data not shown). In the thymus, normal thymic
architecture was lost and BLC was diffusely distributed in
the entire region (Fig. 1 C). Arterial walls were strongly
stained by anti-BLC pAbs presumably due to massive secre-
tion of BLC in the thymus in aged BWF1 mice. RT-PCR
analysis on microdissected cells obtained from kidney cryo-
sections showed that BLC expression was largely confined
to the mononuclear cell infiltrates in aged BWF1 mice (data
not shown). BLC expression in the thymus of similarly aged
NZB and NZW mice was marginal compared with that in
 
aged BWF1 mice (Fig. 1 D, a). Similar levels of PCR prod-
ucts for GAPDH were obtained (not shown). Real-time
PCR analysis on BLC expression in the thymus confirmed
an extremely high magnification of BLC expression in the
thymus of aged BWF1 mice compared with aged NZB and
NZW mice (Fig. 1 D, b). BLC expression in aged NZB
mice was significantly increased in aged NZB mice, al-
though it was much lower than that in BWF1 mice (26.5 
 

 
6.4 versus 696 
 

 
 171-fold increase compared with normal-
ized BLC quantity in young mice).
 
Identification of BLC-producing Cells in Aged BWF1 Mice.
 
FCM analysis showed that CD11b
 

 
CD11c
 

 
 cells were sig-
nificantly increased in the thymus and spleen in aged
BWF1 mice (Fig. 2 A). The percentages of CD11b
 

 
CD11c
 

 
cells in the thymus in young and aged mice were 0.49 
 

 
0.08 (
 
n
 
 
 

 
 4) and 5.58 
 

 
 2.39 (
 
n
 
 
 

 
 4), respectively (
 
P
 
 
 


Figure 2. Identification of BLC-producing cells in aged BWF1 mice. (A) FCM analysis on splenic and thymic cells from young and aged BWF1 mice
stained with FITC-labeled anti-CD11b and PE-labeled anti-CD11c mAbs. A representative FCM profile from four independent experiments is pre-
sented. The percentages of CD11bCD11c cells in the thymus in young and aged mice were 0.49  0.08 (n  4) and 5.58  2.39 (n  4), respectively
(P 
 0.01). In the spleen, those in young and aged mice were 2.37  0.32 (n  4) and 5.70  3.36, respectively (P 
 0.05). (B, a) RT-PCR analysis for
BLC expression on highly purified splenic (Spl) CD4, B, B1, B2, and CD11c cells obtained from aged BWF1 mice. Appropriately stained CD4, B, B1,
and B2 cells were sorted on FCM, and CD11c cells were purified on MACS® magnetic beads coupled with anti-CD11c mAb. One of three indepen-
dent experiments is shown. Similar results were obtained in other experiments. (b) Real-time quantitative PCR on the same samples as Fig. 2 B, a. BLC
quantity in each purified cell population was expressed relative to normalized BLC quantity in the whole splenic cells. PCR reactions were run in tripli-
cate. (C, a) RT-PCR analysis on magnetic beads-purified CD11c cells and sorted CD11bCD11c cells obtained from aged BWF1 thymus (Thy). The
results are representative of three independent experiments. (b) Real-time quantitative PCR on the same samples as Fig. 2 C, a. BLC quantity in each
purified cell population was expressed relative to normalized BLC quantity in the whole thymic cells. (D) Immunohistochemical examinations on thymic
cryosections from young and aged BWF1 mice. 4-micron thick thymic cryosections were stained with anti-CD11b, CD11c, or B220 mAb followed by
HRP-labeled rabbit anti–rat pAb. A representative histology from five young and aged mice was presented.
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0.01). In the spleen, those in young and aged mice were
2.37  0.32 (n  4) and 5.70  3.36, respectively (P 

0.05). CD11bCD11c cells were also slightly increased
in similarly aged NZB mice compared with that in aged
NZW mice (1.07  0.60% in aged NZB mice, 0.13 
0.06% in aged NZW mice; n  3, P 
 0.01), although
the percentage was lower than that in aged BWF1 mice.
RT-PCR analysis on highly purified leukocyte subpop-
ulations demonstrated that BLC was highly expressed in
splenic CD11c cells obtained from aged BWF1 mice,
but not in CD4 T cells or B cells including B1 and B2
cells (Fig. 2 B, a). Enriched BLC expression in splenic
CD11c cells in aged BWF1 mice was confirmed by real-
time quantitative PCR analysis (Fig. 2 B, b). Similar results
were obtained with FCM-sorted CD11b CD11c cells
derived from the thymus of aged BWF1 mice as well as
MACS-purified CD11c cells (Fig. 2 C, a and b).
CD11bCD11c cells in the spleen and thymus in aged
BWF1 mice also highly expressed MHC class II on the cell
surfaces (data not shown). These results suggested that ma-
ture myeloid DCs were the major cell source for BLC in
aged BWF1 mice developing lupus nephritis. In accor-
dance with the enhanced expression of BLC in aged BWF1
mice, many CD11c, CD11b, and B220 cells were infil-
trated in the thymus (Fig. 2 D). It should be noted that
CD11c cells showed a similar localization to CD11b
cells in adjacent thymic cryosections.
B1 and B2 Cells Were Markedly Increased in the Thymus in
Aged BWF1 Mice. Flow cytometric analysis on the thy-
mus revealed that CD4CD8 double-positive T cells
were dramatically decreased in the aged thymus whereas
CD4 single-positive cells and B cells were markedly in-
creased (Fig. 3 A). The percentages of CD4 T cells in
young and aged mice were 16.2  6.0% (n  4) and 51.0 
5.3% (n  4), respectively (P 
 0.001), whereas those of
CD8 T cells were 5.92  1.2% and 11.1  3.3%, respec-
tively (P 
 0.05). Most of the double-negative cells in the
aged thymus turned out to be B cells, including B1 cells
(Fig. 3 A). The total percentage of B cells in the thymus in
young and aged mice was 0.69  0.16 (n  4) and 18.1 
6.3% (n  5), respectively (P 
 0.01). The percentages of
B1 cells in the thymus were 0.28  0.08 (n  4) and 5.15 
2.67% (n  5) in young and aged mice, respectively (P 

0.01), whereas those of B2 cells were 0.35  0.18 and
10.2  5.5%, respectively (P 
 0.01). B1 cells were also
often increased in the spleen and enlarged LNs, including
pulmonary LNs and renal LNs in aged BWF1 mice (data
not shown). The percentages of B1 cells in young and aged
spleen were 4.84  0.7% (n  6) and 7.0  3.83% (n  8),
respectively (P  0.05), whereas those of B2 cells were
31.4  7.8% (6) and 36.2  8.4% (8), respectively (P 
0.05). Dramatic decrease in the number of CD4CD8 T
cells and marked increase in CD4 and B cells in the thy-
mus was not observed in similarly aged NZB and NZW
Figure 3. Dramatic increase of
CD4 T and B cells including B1
cells in the thymus in aged BWF1
mice. (A) Flow cytometric analysis
was performed on thymocytes from
young and aged BWF1 mice. Four-
color analysis was performed on thy-
mocytes using FITC-CD4, Alexa
594-CD8, PE-B220, and APC-CD5.
A representative FCM profile from
four independent experiments is
presented. (B) The percentages of
CD4 T cells in young and aged
mice were 16.2  6.0% (n  4) and
51.0  5.3% (n  4), respectively
(P 
 0.001), whereas those of CD8
T cells were 5.92  1.2% (n  4) and
11.1  3.3% (n  4), respectively
(P 
 0.05). The total percentage of
B cells in the thymus in young and
aged mice was 0.69  0.16 (n  4)
and 18.1  6.3% (n  5), respec-
tively (P 
 0.001). The percentages
of B1 cells in the thymus were 0.28 
0.08 (n  4) and 5.15  2.67% (n 
5) in young and aged mice, respec-
tively (P 
 0.01), whereas those of
B2 cells were 0.35  0.18 (n  4)
and 10.2  5.5% (n  5), respec-
tively (P 
 0.01). *P 
 0.01, **P 

0.001. (C) B1/B2 ratios in the thy-
mus (n  5), the spleen (n  5), and
the peripheral blood (n  4) in aged
BWF1 mice are presented (0.42 
0.13, 0.18  0.14, and 0.13  0.05,
respectively). *P 
 0.01.
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mice (Fig. 3 B). Aged BALB/c mice did not show any ab-
normality in lymphocyte subsets either (data not shown).
B1/B2 ratio in the aged thymus was significantly higher
than that in the spleen and the peripheral blood, suggesting
that B1 cells were accumulated in the thymus in aged
BWF1 mice (Fig. 3 C). Although increase in BLC expres-
sion and the number of B1 cells in the spleen was often ob-
served in aged BWF1 mice, B1/B2 ratio was not statisti-
cally significant.
BLC Preferentially Chemoattracts B1 Cells In Vitro. Chemo-
taxis assay for BLC using highly purified sorted B1 and B2
cells was then performed to examine the differential effect
of BLC on B1 and B2 cells. Interestingly, B1 cells were
chemoattracted towards BLC much more efficiently than
B2 cells (Fig. 4 A). Preferential chemotaxis of B1 cells to-
wards BLC was observed in other mouse strains including
NZB, NZW, BALB/c, and C57BL/6 mice, although the
total number of migrated cells and percentage of input var-
ied in each assay (Fig. 4, A and C). When peritoneal cells
from NZB, NZW, and BWF1 mice were assayed at 0.3
g/ml BLC on the same day on the same plate, a similar
number of cells was migrated (data not shown). Approxi-
mately four times more B1 cells were migrated towards
BLC at the concentration of 0.1 and 0.3 g/ml with a bell-
shaped dose–response curve (Fig. 4 A). Kinetic study also
showed a preferential chemotaxis of B1 cells towards BLC
(Fig. 4 B). Preferential chemotaxis of B1 cells towards BLC
was also observed when whole spleen cells were used and
stained with anti-CD5 and B220 mAbs after chemotaxis as-
says. B1/B2 ratios before and after migration were 0.16 
0.04 and 0.43  0.28 (n  6), respectively (P 
 0.05), sug-
gesting that preferential chemotaxis of B1 cells towards
BLC is not attributed to a possible artifact by anti-CD5 Ab.
A most representative FCM profile is shown in Fig. 4 D.
The percentage of B1 cells in migrated cells was surpris-
ingly increased after chemotaxis in this experiment.
CXCR5 Expression on B1 and B2 Cells. Flow cytomet-
ric analysis on peritoneal B1 and splenic B2 cells using anti-
Figure 4. Preferential chemotaxis of B1 cells towards BLC. (A) Mixture of spleen and peritoneal cells from young BWF1 mice were stained for FITC-
labeled CD5 and PE-B220 and sorted into B1 and B2 cells on an EPICS ELITE® cell sorter and then subjected to BLC chemotaxis assay as described in
Materials and Methods. Migrated cells were counted on an FCM under the constant flow rate. Chemotaxis assays for B1 and B2 cells obtained from each
strain were performed on the same plate on the same day. One of three independent experiments for each mouse strain is presented. Similar results were
obtained in all experiments with a bell-shaped dose–response curve, although total cell number of migrated cells varied in each experiment. (B) Kinetic
study was performed using FCM-sorted B1 and B2 cells at a concentration of 0.3 g/ml rBLC. (C) Chemotaxis assays were also performed on B1 and
B2 cells derived from C57BL/6 and BALB/c mice. One of two independent experiments is presented. A similar result was obtained in the other experi-
ment. (D) Whole spleen cells from young BWF1 mice were used for chemotaxis assay for BLC. After chemotaxis, migrated cells were stained with
FITC-labeled CD5 and PE-B220 mAbs and analyzed on EPICS ELITE®. A typical FCM profile is presented from six chemotaxis assays.
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CXCR5 mAb demonstrated that cell surface expression of
CXCR5 on peritoneal B1 cells was much higher than that
on splenic B2 cells (Fig. 5 A). However, analysis on B1 and
B2 cells in the same tissue localization revealed that the dif-
ference in CXCR5 expression was not so striking as it was
seen between peritoneal B1 and splenic B2 cells, suggesting
that the level of CXCR5 expression on B1 and B2 cells is
dependent on or influenced by tissue localization (Fig. 5
B). Mean fluorescence channels for peritoneal B1 cells and
splenic B2 cells were 12.0  0.76 (n  4) and 2.28  0.46
(n  4), respectively (P 
 0.001). It should be noted that
peritoneal B2 cells show much higher CXCR5 expression
than splenic B2 cells (8.4  0.54 versus 2.28  0.46, re-
spectively; P 
 0.001). On the other hand, splenic B1 cells
have lower CXCR5 expression than peritoneal B1 cells
(5.2  0.92 and 12.0  0,76, respectively, P 
 0.001).
However, both splenic and peritoneal B1 cells showed
higher expression of CXCR5 than B2 cells in the same tis-
sue (Fig. 5 B).
Discussion
BLC (CXCL13), a CXC chemokine, is the only
chemokine so far which is known to specifically chemoat-
tract B cells through the interaction with its receptor
CXCR5 (18, 19). Recent report has also demonstrated that
activated T cells as well as B cells migrated towards BLC
(20). This study demonstrated that BLC was markedly in-
creased in the target organs especially in the thymus and
kidney in aged BWF1 mice whereas BLC was barely de-
tected in these organs in young mice. Reticular pattern of
BLC staining in the cellular infiltrates in the target organs
and high expression of BLC in purified CD11b11c or
CD11c cells strongly suggested that myeloid DCs were
the major cell source for BLC in aged BWF1. Mazzucchelli
et al. (21) recently reported that BLC was expressed in
Helicobacter pylori–induced mucosa-associated lymphoid tis-
sue and gastric lymphoma, suggesting that transformed B
cells were a possible source of BLC. However, it is highly
unlikely that BLC was produced by B cells in aged BWF1
mice because RT-PCR analysis on sorted splenic B cells
including B1 and B2 cells showed a much lower level of
BLC expression than that in CD11c cells. It is also un-
likely that enhanced BLC expression was attributed to
FDCs in aged BWF1 mice because FDCs are generally
considered to be CD11c negative and purified CD11c
cells from aged BWF1 spleen cells were negative for CD35
and FDC-M1 (data not shown). Ansel et al. (22) reported
that BLC staining was detected in CR1 follicular stromal
cells as well as CR1 FDCs in B cell follicles, also indicat-
ing that FDCs are not the only cell source for BLC.
Consistent with marked increase in BLC expression in
the thymus in aged BWF1 mice, many CD11bC11c cells
as well as B cells were infiltrated in the thymus. The pres-
ence of abnormal DCs in thymus may give rise to positive
selection of autoreactive T cells, instead of the normal nega-
tive selection. This possibility was supported by the fact that
CD4 single-positive T cells were in fact markedly increased
in the thymus in aged BWF1 mice whereas CD4CD8 T
cells were dramatically decreased. It is quite likely that au-
toreactive T cells stimulate B cells including B1 cells in the
presence of BLC-producing DCs in the thymus of aged
BWF1 mice. It has been recently reported that CXCR5
CD4 T cells designated as follicular helper T cells (TFH) are
specifically involved in IgG production by B cells (23, 24).
It is also tempting to speculate that cell–cell interaction be-
tween BLC-producing DCs, TFH, and B cells including B1
cells play a pivotal role for IgG autoantibody production in
aged BWF1 mice. Massive IgG autoantibody production
and accumulation in site in the target organs such as the
kidney and the lung would cause more direct damages on
these organs than systemic autoantibody production. In this
context, maturing signals for DCs in the thymus or
chemokine/chemokine receptors involved in trafficking
and localization of BLC producing DCs would be the most
critical element in the development of lupus nephritis.
The thymus is not the only organ where BLC is ex-
pressed, but BLC is constitutively expressed in B cell folli-
Figure 5. Higher CXCR5 expression on B1 than B2 cells. (A) Mix-
ture of spleen and peritoneal cells from young BWF1 mice were stained
with anti-CXCR5, anti-CD5, and anti-B220 mAbs and then analyzed
for CXCR5 expression on gated B1 or B2 population using a FACStar™
FCM. A representative flow cytometric profile from three mice is pre-
sented. Mean fluorescence channels for B1 and B2 cells were 796  18
(n  3) and 113  9.0 (n  3), respectively (P 
 0.001). Staining on
CD5B220 cells was presented as an internal control. Rat IgG control
showed no positive staining. (B) Similar experiments using whole spleen
or peritoneal cells from four mice were performed in addition to the
mixed population and analyzed on an EPICS ELITE® FMC. Mean fluo-
rescence channels for peritoneal B1 cells and splenic B2 cells were 12.0 
0.76 (n  4) and 2.28  0.46 (n  4), respectively (P 
 0.001). It
should be noted that peritoneal B2 cells show much higher CXCR5 ex-
pression than splenic B2 cells (8.4  0.54 versus 2.28  0.46, respec-
tively; P 
 0.001). On the other hand, splenic B1 cells have lower
CXCR5 expression than peritoneal B1 cells (5.2  0.92 and 12.0 
0.76, respectively; P 
 0.001).
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cles in secondary lymphoid organs and also in other organs
including the lung and liver. We do not know at this point
whether BLC-expressing cells in these organs play the
same role in activating T and B cells as those in the thymus
of aged BWF1 mice. BLC expression in the second lym-
phoid organs in young mice is most likely derived from
FDCs in B cell follicles. It has not been proved, however,
that FDCs present antigens to T cells directly in vivo. Fur-
thermore, Gray et al. (25) suggested that FDCs did not
synthesize MHC class II molecules, but acquire MHC
molecules shed from B cells. Therefore, antigen presenting
ability of FDCs might be much less efficient than mature
DCs. On the other hand, BLC expressing cells in nonlym-
phoid organs may not be DCs, but specialized macro-
phages such as alveolar macrophages and Kupffer cells. We
favor the idea that only mature DCs producing BLC ef-
fectively activate autoreactive T and B cells in a cognate
manner. Lack of mononuclear cell infiltration in the liver
of aged BWF1 mice is a matter of interest. Limmer et al.
(26) recently reported that hepatic endothelial cells in-
duced antigen-specific T cell tolerance. Autoreactive T cell
response in the liver could be tolerated or suppressed in
aged BWF1 mice. Alternatively, DC maturation may be
inhibited in the liver microenvironment.
BLC expression in the thymus slightly, but significantly
increased in aged NZB, but not in NZW mice, although
the level of BLC expression was much lower than that in
aged BWF1 mice. It was also observed that the percentage
of CD11bCD11c cells in aged NZB mice were signifi-
cantly higher than that in aged NZW mice, suggesting that
BLC expression in the thymus is not merely an age-related
phenomenon. NZB mice spontaneously develop autoim-
mune hemolytic mediated by B1 cells (15, 16), but never
develop lupus nephritis, suggesting that other factors are re-
quired for the full development of lupus nephritis. In fact,
many candidate genes have been mapped so far by genetic
analysis on responsible genes for murine lupus (1–3). It is,
therefore, likely that expression of some of the polymor-
phic candidate genes derived from NZW strain are in-
volved in the development of lupus nephritis in addition to
BLC upregulation in BWF1 mice. Alternatively, the differ-
ence in the number of CD11bCD11c cells between aged
BWF1 and NZB thymus (5.58 versus 1.07%) is critical and
enough for induction of massive T cell activation in the
thymus. Ansel et al. (22) recently reported the presence of a
positive feedback mechanism between BLC and LT12
in the formation of primary B cell follicles, where BLC in-
duces LT12 expression by B cells and LT12 then
promotes maturation of FDCs. Possible difference in the
level of LT12 expression might result in different matu-
ration stage of DCs in the thymus. It was also reported that
circulating zTNF4 (B lymphocyte stimulator [Blys], B cell
activation factor from the TNF family [BAFF], TNF and
apoptosis ligand–related leukocyte-expressed ligand 1 [TALL-
1], TNF homologue that activates apoptosis, nuclear factor
B, and c-Jun NH2-terminal kinase [THANK]), a potent
coactivator of B cells in vivo and in vitro, was abundant in
BWF1 mice and MRL/lpr mice during the development of
SLE, and that transgenic mice overexpressing zTNF4 in
lymphoid cells developed SLE-like symptoms and ex-
panded B1 cells in the spleen (27–31). Autoantibody pro-
duction would be greatly accelerated if BLC-expressing
DCs are potent zTNF4 producers.
The finding of preferential chemotactic activity of BLC
for B1 cells is of particular interest. Preferential chemotactic
activity of BLC for B1 cells was also observed in NZB,
NZW, C57BL/6, and BALB/c mice, suggesting that B1
cells have a unique property to migrate towards BLC. Flow
cytometric analysis on CXCR5 using anti-CXCR5 mAb
showed higher expression of CXCR5 molecules on B1
cells than B2 cells. It is, therefore, most likely that preferen-
tial chemotactic activity of BLC on B1 cells is attributed to
higher CXCR5 expression on B1 cells than B2 cells. How-
ever, it should be noted that CXCR5 expression on B1
and B2 cells is different depending on their tissue localiza-
tion. Splenic B1 cells express lower CXCR5 than those in
the peritoneum whereas peritoneal B2 cells do express
higher CXCR5 than splenic B2 cells. Edward et al. (32) re-
cently reported the developmental switches in chemokine
response profiles during B cell differentiation and matura-
tion. They observed no differences in BLC chemotaxis nor
in CXCR5 expression between B1 and B2 cells. The dif-
ference between their results and ours is possibly attributed
to relatively high expression of CXCR5 on peritoneal B2
cells because they used C57BL/6 peritoneal cells instead of
purified B1 and B2 cells. We also observed high back-
ground migration in chemotaxis chambers with 5 m pore
size which they used. Finally, BLC concentration (500 nM)
they used was much higher than that for maximum che-
motaxis in our experimental system. It is unlikely that prior
staining with anti-CD5 and B220 Abs to chemotaxis assay
affected B1 and B2 cell migration because significant in-
crease in B1/B2 ratio was also observed when unstained
whole spleen cells were used. With regard to the different
result on CXCR5 expression on B1 and B2 cells, it is most
likely attributed to use of anti-CXCR5 mAb in our exper-
iments instead of polyclonal Ab. The fact that many B cells
were infiltrated in the thymus in aged BWF1 mice and B1/
B2 ratio was significantly higher than that in the spleen and
peripheral blood suggested that B1 cells were also preferen-
tially recruited in vivo towards BLC. Higher B1/B2 ratio
in the thymus in aged BWF1 mice than other BLC consti-
tutively expressing-organs might be attributed to potent
antigen presenting ability of BLC producing DCs in the
thymus and subsequent accumulation of T cell factors re-
quired for B1 cell expansion (IL-5, for example). In other
words, BLC-producing mature DCs in the thymus and
other target organs, but not FDCs or specialized macro-
phages, could play a role in the development of systemic au-
toimmune disease. Although B1 cells have long been con-
sidered to be involved in IgM autoantibody production, no
direct evidence for the development of SLE has been pro-
vided. Pathogenic IgG autoantibody production by B1
cells may be initiated in the thymus of aged BWF1 mice in
the presence of autoreactive CD4 T cells and mature my-
eloid DCs.
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Collectively, we have demonstrated for the first time
that BLC expression by DCs was strikingly enhanced in the
target organs in a murine model for SLE and that BLC
preferentially chemoattracts B1 cells. These results suggest
that aberrant trafficking and localization of BLC-producing
DCs could cause tolerance breakdown in the thymus and
induce systemic autoantibody production. This study also
give us novel insight into SLE as a disorder in chemokine/
DC dynamics and may provide a new therapeutic approach
to regulate the disease by targeting the chemokine/chemo-
kine receptor system.
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